DISSECTING THE RENAL CELL CARCINOMA MICROENVIRONMENT TO IDENTIFY DETERMINANTS OF OUTCOMES TO IMMUNE CHECKPOINT-BASED THERAPY
$0FY2025Defense Health AgencyDOD
Brigham & Womens Hospital Inc
Investigators
View source on USAspending →DISSECTING THE RENAL CELL CARCINOMA MICROENVIRONMENT TO IDENTIFY DETERMINANTS OF OUTCOMES TO IMMUNE CHECKPOINT-BASED THERAPY · GrantIndex